Capital Rx's Philip Vecchiolli explains how new technology provides health plans with greater transparency and an improved member experience.
14 suggestions for employers and other plan sponsors to optimize pharmacy benefits spend from Capital Rx's leadership team.
Capital Rx's JUDI® wins the 2022 Fierce Innovation Award in the Financial/Operational Solutions category.
Highlights from Health Benefits Nation '22 and the Solving the Drug Spend Crisis: What Employers Can (Should) Do panel discussion...
On May 23, 2022, Capital Rx’s Chief Growth Officer, Kristin Begley, was joined by an exceptional panel of experts on stage at thINc360.
Capital Rx's JUDI™ Enterprise Pharmacy Platform modernizes prescription and healthcare infrastructure to power the 21st century of care delivery
Thank you to Forbes’ Katie Jennings for expertly summarizing the challenges consumers face as a result of rising drug prices, as well as how Capital Rx’s $106M Series C funding will help accelerate the company's mission.
The Consolidated Appropriations Act of 2021 (CAA) established protections for consumers related to surprise billing and transparency in healthcare. The goal of the Act is consistent with the federal government’s desire to reduce the inflation of healthcare spending by giving a clearer line of sight into a variety of opaque healthcare cost drivers, including those that have driven persistent inflation in pharmacy cost trend for plan sponsors.